The Analyst Verdict: OptimizeRx In The Eyes Of 6 Experts
The Analyst Verdict: OptimizeRx In The Eyes Of 6 Experts
分析师的看法：6位专家眼中的OptimizeRx
In examining recent analyst actions...Ratings for OptimizeRx (NASDAQ:OPRX) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中，由6位分析师提供的OptimizeRx（纳斯达克：OPRX）的评级展示了看好和看淡的观点混合。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，提供了对过去30天情绪变化的洞察，并与前几个月进行了比较。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $8.25, along with a high estimate of $16.00 and a low estimate of $5.00. A 44.26% drop is evident in the current average compared to the previous average price target of $14.80.
分析师提供了更深入的见解，设定了12个月的价格目标，表明平均目标为8.25美元，最高估计为16.00美元，最低估计为5.00美元。目前的平均价格与之前的14.80美元价格目标相比，明显下降了44.26%。
Deciphering Analyst Ratings: An In-Depth Analysis
分析师评级解读：深入分析
In examining recent analyst actions...
通过考察最...
登录免费看全文
登录/注册
资讯热榜
更新时间